Grogan Jane has filed 19 insider transactions across 1 company since November 2023.
Most recent transaction: a grant/award of 8450 shares of BIOGEN INC. ($BIIB) on February 13, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 13, 2026 | BIOGEN INC. | $BIIB | Grogan Jane | Head of Research | A | Restricted Stock Unit | 8450 | $0.00 | 8,450.0000 | 170,500,000 | 9999.99% | 0.00% |
| Feb. 6, 2026 | BIOGEN INC. | $BIIB | Grogan Jane | Head of Research | M | Restricted Stock Unit | 1873 | $0.00 | 3,747.0000 | 170,500,000 | 33.33% | 0.00% |
| Feb. 6, 2026 | BIOGEN INC. | $BIIB | Grogan Jane | Head of Research | M | Common Stock | 1385 | $0.00 | 3,176.0000 | 170,500,000 | 77.33% | 0.00% |
| Feb. 6, 2026 | BIOGEN INC. | $BIIB | Grogan Jane | Head of Research | F | Common Stock | 584 | $201.18 | 4,058.0000 | 170,500,000 | 12.58% | 0.00% |
| Feb. 6, 2026 | BIOGEN INC. | $BIIB | Grogan Jane | Head of Research | M | Common Stock | 1873 | $0.00 | 4,642.0000 | 170,500,000 | 67.64% | 0.00% |
| Feb. 6, 2026 | BIOGEN INC. | $BIIB | Grogan Jane | Head of Research | F | Common Stock | 407 | $201.18 | 2,769.0000 | 170,500,000 | 12.81% | 0.00% |
| Feb. 6, 2026 | BIOGEN INC. | $BIIB | Grogan Jane | Head of Research | M | Restricted Stock Unit | 1385 | $0.00 | 1,385.0000 | 170,500,000 | 50.00% | 0.00% |
| Oct. 31, 2025 | BIOGEN INC. | $BIIB | Grogan Jane | Head of Research | F | Common Stock | 337 | $154.27 | 1,791.0000 | 170,500,000 | 15.84% | 0.00% |
| Oct. 31, 2025 | BIOGEN INC. | $BIIB | Grogan Jane | Head of Research | M | Common Stock | 695 | $0.00 | 2,128.0000 | 170,500,000 | 48.50% | 0.00% |
| Oct. 31, 2025 | BIOGEN INC. | $BIIB | Grogan Jane | Head of Research | M | Restricted Stock Unit | 695 | $0.00 | 695.0000 | 170,500,000 | 50.00% | 0.00% |
| Feb. 7, 2025 | BIOGEN INC. | $BIIB | Grogan Jane | Head of Research | F | Common Stock | 443 | $141.35 | 1,433.0000 | 169,500,000 | 23.61% | 0.00% |
| Feb. 7, 2025 | BIOGEN INC. | $BIIB | Grogan Jane | Head of Research | M | Restricted Stock Unit | 1385 | $0.00 | 2,770.0000 | 169,500,000 | 33.33% | 0.00% |
| Feb. 6, 2025 | BIOGEN INC. | $BIIB | Grogan Jane | Head of Research | A | Restricted Stock Unit | 5620 | $0.00 | 5,620.0000 | 169,500,000 | 9999.99% | 0.00% |
| Feb. 7, 2025 | BIOGEN INC. | $BIIB | Grogan Jane | Head of Research | M | Common Stock | 1385 | $0.00 | 1,876.0000 | 169,500,000 | 282.08% | 0.00% |
| Nov. 1, 2024 | BIOGEN INC. | $BIIB | Grogan Jane | Head of Research | F | Common Stock | 204 | $173.79 | 491.0000 | 169,500,000 | 29.35% | 0.00% |
| Nov. 1, 2024 | BIOGEN INC. | $BIIB | Grogan Jane | Head of Research | M | Common Stock | 695 | $0.00 | 695.0000 | 169,500,000 | 9999.99% | 0.00% |
| Nov. 1, 2024 | BIOGEN INC. | $BIIB | Grogan Jane | Head of Research | M | Restricted Stock Unit | 695 | $0.00 | 1,390.0000 | 169,500,000 | 33.33% | 0.00% |
| Feb. 7, 2024 | BIOGEN INC. | $BIIB | Grogan Jane | Head of Research | A | Restricted Stock Unit | 4155 | $0.00 | 4,155.0000 | 168,700,000 | 9999.99% | 0.00% |
| Nov. 1, 2023 | BIOGEN INC. | $BIIB | Grogan Jane | Head of Research | A | Restricted Stock Unit | 2085 | $0.00 | 2,085.0000 | 167,900,000 | 9999.99% | 0.00% |